A Multivariate Approach for the Determination of the Optimal Mixing Ratio of the Non-Strong Interacting Co-Amorphous System Carvedilol-Tryptophan

被引:13
作者
Di, Rong [1 ]
Liu, Jingwen [1 ]
Grohganz, Holger [1 ]
Rades, Thomas [1 ]
机构
[1] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark
关键词
co-amorphous systems; optimal mixing ratio; glass transition temperature; principal component analysis;
D O I
10.3390/molecules26040801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Converting crystalline compounds into co-amorphous systems is an effective way to improve the solubility of poorly water-soluble drugs. It is, however, of critical importance for the physical stability of co-amorphous systems to find the optimal mixing ratio of the drug with the co-former. In this study, a novel approach for this challenge is presented, exemplified with the co-amorphous system carvedilol-tryptophan (CAR-TRP). Following X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) of the ball-milled samples to confirm their amorphous form, Fourier-transform infrared spectroscopy (FTIR) and principal component analysis (PCA) were applied to investigate intermolecular interactions. A clear deviation from a purely additive spectrum of CAR and TRP was visualized in the PCA score plot, with a maximum at around 30% drug (mol/mol). This deviation was attributed to hydrogen bonds of CAR with TRP ether groups. The sample containing 30% drug (mol/mol) was also the most stable sample during a stability test. Using the combination of FTIR with PCA is an effective approach to investigate the optimal mixing ratio of non-strong interacting co-amorphous systems.
引用
收藏
页数:8
相关论文
共 23 条
[1]   DENSITIES OF SEVERAL PROTEINS AND L-AMINO ACIDS IN DRY STATE [J].
BERLIN, E ;
PALLANSC.MJ .
JOURNAL OF PHYSICAL CHEMISTRY, 1968, 72 (06) :1887-&
[2]   Recent advances in co-amorphous drug formulations [J].
Dengale, Swapnil Jayant ;
Grohganz, Holger ;
Rades, Thomas ;
Lobmann, Korbinian .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 100 :116-125
[3]   IDEAL COPOLYMERS AND THE 2ND-ORDER TRANSITIONS OF SYNTHETIC RUBBERS .1. NON-CRYSTALLINE COPOLYMERS [J].
GORDON, M ;
TAYLOR, JS .
JOURNAL OF APPLIED CHEMISTRY, 1952, 2 (09) :493-500
[4]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12
[5]  
Hauss D.J.., 2007, Oral Lipid-Based Formulations Enhancing the Bioavailability of Poorly Water-Soluble Drugs, V170
[6]   Influence of variation in molar ratio on co-amorphous drug-amino acid systems [J].
Jensen, Katrine Tarp ;
Larsen, Flemming Hofmann ;
Lobmann, Korbinian ;
Rades, Thomas ;
Grohganz, Holger .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 107 :32-39
[7]  
Jensen Katrine Tarp, 2014, Pharmaceutics, V6, P416, DOI 10.3390/pharmaceutics6030416
[8]   Co-former selection for co-amorphous drug-amino acid formulations [J].
Kasten, Georgia ;
Lobmann, Korbinian ;
Grohganz, Holger ;
Rades, Thomas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 557 :366-373
[9]   The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations [J].
Kissi, Eric Ofosu ;
Kasten, Georgia ;
Lobmann, Korbinian ;
Rades, Thomas ;
Grohganz, Holger .
MOLECULAR PHARMACEUTICS, 2018, 15 (09) :4247-4256
[10]   Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion [J].
Knopp, Matthias Manne ;
Wendelboe, Johan ;
Holm, Rene ;
Rades, Thomas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 130 :290-295